Our Science & R&D
An AI-Enabled Research & Development Framework
Idrak Pharma is developing an AI-enabled Research & Development framework designed to support nutraceutical product design through structured scientific analysis, formulation logic, and internal decision-making discipline.
The company’s R&D approach integrates computational tools, scientific literature synthesis, and human scientific oversight to improve the quality, consistency, and traceability of product development—while operating strictly within the U.S. dietary supplement regulatory framework.
R&D Operating Model
The R&D system is structured as a disciplined, multi-stage process:
Systematic review and synthesis of peer-reviewed literature, biological pathways, and ingredient-level evidence relevant to targeted health functions.
Use of computational methods and AI-supported analysis to map mechanisms of action, ingredient interactions, and formulation logic.
Translation of research insights into formulation strategies that prioritize ingredient synergy, bioavailability considerations, and scientific plausibility.
Mandatory human review of all research outputs, alignment with DSHEA and FTC structure/function requirements, and internal quality control.
Creation of internal scientific briefs, rationale documentation, and decision records to support transparency and long-term scalability.
Role of Artificial Intelligence
Artificial intelligence is used as a research acceleration and organizational tool, not as a substitute for scientific judgment.
AI supports:
• Literature analysis and synthesis
• Research organization and knowledge management
• Early-stage modeling and hypothesis exploration
• Internal documentation and workflow efficiency
All AI-assisted outputs are reviewed by human decision-makers prior to implementation.
Operating Principles
Idrak Pharma’s R&D activities are guided by the following principles:
Product development decisions are grounded in scientific rationale, not marketing trends.
All research and communication adhere to dietary supplement regulatory boundaries.
Final responsibility for decisions remains with human leadership.
Systems are built to support long-term operational growth and future expansion.
Regulatory Alignment
Idrak Pharma develops dietary supplements in accordance with applicable U.S. regulations and maintains clear separation between research activities and medical or disease-related claims.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Long-Term R&D Direction
The current R&D framework is designed to scale progressively—supporting increasing scientific depth, operational rigor, and technological capability as the organization grows.